- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
CRISIL Ratings has upgraded Emcure Pharmaceuticals' long-term bank loan facilities to 'CRISIL AA-/Positive' from 'CRISIL AA-/Stable'. This signals an improved outlook for the company. CRISIL also reaffirmed the short-term rating at 'CRISIL A1+'.